Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Comment by davikingon Mar 29, 2018 3:46pm
126 Views
Post# 27805016

RE:Cheers 4 the commentary on the thoughts and '1 more thing'..

RE:Cheers 4 the commentary on the thoughts and '1 more thing'..You are pretty definite about :
"...bear in mind, that in the real world usage of PMX, it is now common-place to use additional cartridges beyond the limit of 2 in the Euphrates Trial...."
Just based on our esteemed CEO's words in Oct./16 or you have other knowledge? Very bold statement without backup! Our CEO's famous words before the Oct16 were squelched by the announcement that month so not sure I would believe anything else from him.
Just saying.
 
Bullboard Posts